Early access programs—also known as expanded access or compassionate use programs—are sometimes offered by pharmaceutical companies when a drug is in the later stages of clinical trials, particularly if theContinue reading "Early Access Program for Pritelivir"

Herpes Cure Advocacy is excited to share we are a member of the World Patients Alliance. World Patients Alliance is the largest umbrella organization of patients and patients-organizations around theContinue reading "Herpes Cure Advocacy Joins the World Patients Alliance"

As we reflect on the past year, we are thrilled to share our 2024 Annual Report with you. This report offers a comprehensive look at the impact we’ve achieved together,Continue reading "2024 HCA Annual Report"

BIG ANNOUNCEMENT: Herpes Cure Advocacy is fundraising for a new project, to develop an IMPACT REPORT! Help us more clearly DEFINE THE PROBLEM we are trying to solve with a more comprehensiveContinue reading "The Campaign to Create Change"

For the first time since its founding in 1946, the Centers for Diseases Control and Prevention (CDC) is now adding herpes prevention and control activities including clinical guideline development, surveillanceContinue reading "Latest Advocacy Wins for HCA!"

Sponsorship Opportunity The Herpes Cure Pipeline 4.0 is a report and resource outlining the status of active pre-clinical research for new therapies and vaccines (with intent of clinical trials) andContinue reading "Sponsor The Herpes Cure Pipeline 4.0"

October 15, 2024 - Notice of Funding Opportunity (NOFO) New Therapeutic Strategies for Genital Herpes The purpose of this notice of funding opportunity (NOFO) is to stimulate the development ofContinue reading "Funding News for Herpes Vaccines"